These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25913748)

  • 1. Adult phenylketonuria presenting with subacute severe neurologic symptoms.
    Seki M; Takizawa T; Suzuki S; Shimizu T; Shibata H; Ishii T; Hasegawa T; Suzuki N
    J Clin Neurosci; 2015 Aug; 22(8):1361-3. PubMed ID: 25913748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. True Restriction in Diffusion-Weighted Imaging in a Mistreated Patient With Phenylketonuria.
    Palaiodimou L; Zompola C; Lachanis S; Mylona V; Theodorou A; Papagiannopoulou G; Kotsali-Peteinelli V; Foska A; Kasti A; Skouma A; Tsivgoulis G
    Neurologist; 2020 Dec; 26(1):20-21. PubMed ID: 33394907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic resonance imaging of the brain in phenylketonuria].
    Izumi M; Yamazaki H; Nakabayashi H; Owada M
    No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism.
    Tufekcioglu Z; Cakar A; Bilgic B; Hanagasi H; Gurvit H; Emre M
    Neurocase; 2016 Jun; 22(3):273-5. PubMed ID: 26962957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of the brain in phenylketonuria.
    Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D
    Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spasticity and white matter abnormalities in adult phenylketonuria.
    McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonic perseveration in the subacute stage of Japanese encephalitis.
    Ono Y; Manabe Y; Sakai K; Hayashi Y; Abe K
    J Neurol Sci; 2006 Dec; 251(1-2):107-9. PubMed ID: 17097112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change.
    Cleary MA; Walter JH; Wraith JE; White F; Tyler K; Jenkins JP
    J Pediatr; 1995 Aug; 127(2):251-5. PubMed ID: 7636650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
    Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
    Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.
    Pietz J; Meyding-Lamadé UK; Schmidt H
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S69-73. PubMed ID: 8828614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological deterioration in young adults with phenylketonuria.
    Thompson AJ; Smith I; Brenton D; Youl BD; Rylance G; Davidson DC; Kendall B; Lees AJ
    Lancet; 1990 Sep; 336(8715):602-5. PubMed ID: 1975386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological and imaging phenotypes of adults with untreated phenylketonuria: new cases and literature review.
    Wang MW; Wu CJ; Zhang ZQ
    J Neurol; 2023 Aug; 270(8):4060-4079. PubMed ID: 37162580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An adult patient with phenylketonuria before and one year after reinstitution of diet therapy].
    Tiefenthaler M; Seidl R; Scheibenreiter S; Wandl-Vergesslich K; Stöckler-Ipsiroglu S
    Wien Klin Wochenschr; 1999 Jan; 111(1):33-6. PubMed ID: 10067268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological manifestations in adults with phenylketonuria: new cases and review of the literature.
    Jaulent P; Charriere S; Feillet F; Douillard C; Fouilhoux A; Thobois S
    J Neurol; 2020 Feb; 267(2):531-542. PubMed ID: 31701331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients.
    Leuzzi V; Trasimeni G; Gualdi GF; Antonozzi I
    J Inherit Metab Dis; 1995; 18(5):624-34. PubMed ID: 8598645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of primary progressive multiple sclerosis with onset of memory impairment].
    Yamashita K; Nomura T; Ohyagi Y; Taniwaki T; Furuya H; Kuwabara Y; Kira J
    Rinsho Shinkeigaku; 2005 May; 45(5):351-6. PubMed ID: 15960171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal serum phenylalanine for adult patients with phenylketonuria.
    Okano Y; Nagasaka H
    Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients.
    Ding XQ; Fiehler J; Kohlschütter B; Wittkugel O; Grzyska U; Zeumer H; Ullrich K
    J Magn Reson Imaging; 2008 May; 27(5):998-1004. PubMed ID: 18425822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.